Vaxil Provides Update of Conversion of Previously Issued Convertible Debt and the Granting of Options
17 sept. 2020 08h30 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 17, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Positive Results on CorVax™ in vivo Study
08 sept. 2020 08h40 HE
|
Vaxil Bio Ltd.
NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Update on In Vivo Study
27 août 2020 10h51 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Cancels Brokered Private Placement
31 juil. 2020 16h30 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, July 31, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Pre-Clinical and Business Update
20 juil. 2020 08h52 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, July 20, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Private Placement Extension
29 juin 2020 16h05 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, June 29, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Brokered Private Placement
26 mai 2020 07h55 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, May 26, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Collaboration Agreement With The Tel Aviv Sourasky Medical Center (Ichilov Hospital), Israel’s Leading Tertiary Care Facility
05 mai 2020 09h00 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Audited Annual Results and Provides Business Update
28 avr. 2020 09h10 HE
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, April 28, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
CORRECTION: VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT
13 avr. 2020 13h58 HE
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 13, 2020 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated at 8:30 AM, April 13th....